Bupropion and dextromethorphan for reduction of suicide risk in depression patients | Patent Number 11896563

US 11896563 B2
Application Number18323714
Publication NumberUS 20230293456 A1
Pendency8 months, 24 days
Filled DateMay 25, 2023
Priority DateDec 1, 2020
Publication DateSep 21, 2023
Expiration DateNov 30, 2040
Inventor/ApplicantsHerriot Tabuteau
ExaminesWEDDINGTON, KEVIN E
Art Unit1629
Technology Center1600
Assignments
Antecip Bioventures Ii Llc Axsome
Current
Antecip Bioventures Ii Llc AxsomeAxsome Therapeutics Inc.
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.